A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528

NCT00483041 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Study is replaced by MI-CP198 per CPM.

Conditions

Asthma

Interventions

OTHER: PLACEBO
BIOLOGICAL: MEDI528 9 mg/kg

Sponsor

MedImmune LLC